Novartis Offers New Sandostatin LAR Depot Co-Pay Assistance Program
A new co-pay assistance program for carcinoid syndrome patients taking Sandostatin® LAR Depot has been established by Novartis Pharmaceuticals Corporation, effective February 2014.
With the Sandostatin® LAR Depot Co-Pay Assistance Program, eligible…READ MORE
First Meeting of New Southern Carcinoid and NET Support Group in Tennessee
All interested members of the carcinoid/neuroendocrine tumor community are invited to attend the first meeting of the newly formed Southern Carcinoid and NET Support Group, serving the community in Tennessee, Kentucky and Mississippi.READ MORE
BerriHealth Supports Carcinoid and Neuroendocrine Tumor Research
BerriHealth, a leader in providing high-quality black raspberry powder for clinical trials and directly to consumers online, has donated a portion of their 2013 sales to New Orleans Louisiana Neuroendocrine Tumor Specialists (NOLANETS), led by Dr.…READ MORE
First Ever Global Survey for Carcinoid & Neuroendocrine Tumor (NET) Patients
Participate in the first ever global survey specifically focused on NET (neuroendocrine tumor) cancer!
Please help the Carcinoid Cancer Foundation and the Caring for Carcinoid Foundation – both members of the International Neuroendocrine Cancer…READ MORE
2014 National NET Cancer Patient Conference — Registration Now Open
Carcinoid and NET (neuroendocrine tumor) cancer patients, caregivers and family members, as well as physicians and other health professionals, have a unique opportunity to learn more about NET cancer, including the latest information about diagnosis…READ MORE
New Jersey Carcinoid Cancer NETwork Conference Videos Now Available
Carcinoid and neuroendocrine tumor (NET) patients, physicians, caregivers, support group leaders and patient advocates gathered to learn more from nationally and internationally recognized carcinoid/NET specialists and local physician specialists…READ MORE
Mobile Survey for Carcinoid Syndrome Community
Carcinoid syndrome patients, caregivers, and advocates in the carcinoid syndrome community are invited to participate in an exclusive mobile survey being conducted by WEGO Health via Truvio.
WEGO Health is an organization committed to empowering…READ MORE
10 Highlights of the Year 2013 for the Carcinoid and Neuroendocrine Tumor Community
As the Carcinoid Cancer Foundation looks back on the year 2013, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past…READ MORE
Carcinoid and Neuroendocrine Tumors and Social Security Disability Benefits
Carcinoid tumors are usually slow growing tumors that arise from the neuroendocrine system, which produces hormones. Many carcinoids begin in the digestive track and can lead to carcinoid syndrome, which refers to an array of symptoms that occur as …READ MORE
Discover Something New in Carcinoid Syndrome
For patients who suffer from carcinoid syndrome – with symptoms such as diarrhea, frequent bowel movements, abdominal pain, and flushing – that is not adequately controlled by their current somatostatin analog therapy, there is an opportunity to participate…READ MORE